Sernova Corp. (TSE:SVA – Get Free Report) shares were up 6.7% during mid-day trading on Tuesday . The company traded as high as C$0.16 and last traded at C$0.16. Approximately 103,406 shares were traded during mid-day trading, a decline of 17% from the average daily volume of 124,361 shares. The stock had previously closed at C$0.15.
Sernova Price Performance
The stock’s fifty day moving average price is C$0.17 and its 200-day moving average price is C$0.18. The company has a debt-to-equity ratio of -4.40, a quick ratio of 18.11 and a current ratio of 0.32. The firm has a market cap of C$47.66 million, a PE ratio of -2.90 and a beta of 0.67.
About Sernova
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.
Further Reading
- Five stocks we like better than Sernova
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- CAVA Stock Looking for Direction After Earnings Miss
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Small AI Stocks Ready to Explode (All Under $20)
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
